---
title: "Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295849877.md"
description: "Inovio Pharmaceuticals (INO) shares surged 16.90% to $0.90, marking its fourth consecutive day of gains and outperforming competitors like Johnson & Johnson and Pfizer. Trading volume reached 12.7 million, significantly exceeding the 50-day average. The stock remains 69.78% below its 52-week high of $2.98 set in September."
datetime: "2026-08-13T21:26:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295849877.md)
  - [en](https://longbridge.com/en/news/295849877.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295849877.md)
generator: "portal-rs"
---

# Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. (INO) surged 16.90% to $0.90 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.81% to 26,803.03 and the Dow Jones Industrial Average rising 0.13% to 53,839.99.

This was the stock's fourth consecutive day of gains.

Inovio Pharmaceuticals Inc. closed 69.78% short of its 52-week high of $2.98, which the company achieved on September 9th.

The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.47% to $262.08, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. (PFE) rose 1.86% to $26.80.

Trading volume (12.7 M) eclipsed its 50-day average volume of 2.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-13-26 1726ET

### Related Stocks

- [INO.US](https://longbridge.com/en/quote/INO.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Inovio to present at Cantor Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297692030.md)
- [Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/298077556.md)
- [Inovio publishes Q2 2026 financial results presentation focusing on INO-3107 BLA review progress](https://longbridge.com/en/news/295713543.md)
- [Inovio Pharmaceuticals (NASDAQ:INO) Releases Quarterly Earnings Results, Beats Expectations By $0.15 EPS](https://longbridge.com/en/news/295718213.md)
- [BUZZ-Mid-cap drugmakers face limited impact from Trump drug pricing deals, analysts say](https://longbridge.com/en/news/297637201.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**